Idexx Laboratories, Inc. logo

IDXX

Idexx Laboratories, Inc.

$468.2

Earnings Summary

Revenue
$964.1Mn
Net Profits
$235.58Mn
Net Profit Margins
24.44%
PE Ratio
45.66

Highlights

Revenue:

Idexx Laboratories, Inc.’s revenue jumped 7.1% since last year same period to $964.1Mn in the Q1 2024. On a quarterly growth basis, Idexx Laboratories, Inc. has generated 6.93% jump in its revenue since last 3-months.

Net Profits:

Idexx Laboratories, Inc.’s net profit jumped 10.06% since last year same period to $235.58Mn in the Q1 2024. On a quarterly growth basis, Idexx Laboratories, Inc. has generated 21.11% jump in its net profits since last 3-months.

Net Profit Margins:

Idexx Laboratories, Inc.’s net profit margin jumped 2.76% since last year same period to 24.44% in the Q1 2024. On a quarterly growth basis, Idexx Laboratories, Inc. has generated 13.26% jump in its net profit margins since last 3-months.

PE Ratio:

Idexx Laboratories, Inc.’s price-to-earnings ratio after this Q1 2024 earnings stands at 45.66.

Earnings per share (EPS) Estimates

Earnings per share (EPS) estimates of the Idexx Laboratories, Inc. post its latest quarter earnings

EPS Estimate Current Quarter
2.88
EPS Estimate Current Year
2.88

Highlights

EPS Estimate Current Quarter:

Idexx Laboratories, Inc.’s earning per share (EPS) estimates for the current quarter stand at 2.88 - a 7.87% jump from last quarter’s estimates.

EPS Estimate Current Year:

Idexx Laboratories, Inc.’s earning per share (EPS) estimates for the current year stand at 2.88.

Key Ratios

Key ratios of the Idexx Laboratories, Inc. post its Q1 2024 earnings

Earning Per Share (EPS)
2.81
Return on Assets (ROA)
0.23
Return on Equity (ROE)
0.72

Highlights

Earning Per Share (EPS):

Idexx Laboratories, Inc.’s earning per share (EPS) jumped 10.2% since last year same period to 2.81 in the Q1 2024. This indicates that the Idexx Laboratories, Inc. has generated 10.2% annual rate of jump in its earning per share (EPS) in the last 4 quarters.

Return on Assets (ROA):

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Idexx Laboratories, Inc.’s return on assets (ROA) stands at 0.23.

Earning Per Share (EPS):

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Idexx Laboratories, Inc.’s return on equity (ROE) stands at 0.72.

Earnings Calendar

Earnings DateEstimated EPSReported EPSSurprise %
2024-05-01
2.67
2.81
5.24%

Discover More Earning Stocks in Health Technology Sector